Clinical Trial

A Study of HS-20110 in Participants With Advanced Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is an open-label, multicenter study to evaluate the safety and tolerability of HS-20110 in participants with advanced solid malignant tumors
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-03-18; most recent amendment 2026-04-17.
Status change: Not Yet Recruiting → Recruiting 2025-06-19
Trial Details
NCT Number NCT06892379
Lead Sponsor Hansoh BioMedical R&D Company
Collaborators: Hoffmann-La Roche
Conditions Solid Tumors
Enrollment 475 participants
Start Date 2025-02-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20